<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bornhauser B</submitter><funding>Swiss National Science Foundation</funding><pagination>4052-4064</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7479947</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>4(17)</volume><pubmed_abstract>Most relapses of acute lymphoblastic leukemia (ALL) occur in patients with a medium risk (MR) for relapse on the Associazione Italiana di Ematologia e Oncologia Pediatrica and Berlin-Frankfurt-Münster (AIEOP-BFM) ALL protocol, based on persistence of minimal residual disease (MRD). New insights into biological features that are associated with MRD are needed. Here, we identify the glycosylphosphatidylinositol-anchored cell surface protein vanin-2 (VNN2; GPI-80) by charting the cell surface proteome of MRD very high-risk (HR) B-cell precursor (BCP) ALL using a chemoproteomics strategy. The correlation between VNN2 transcript and surface protein expression enabled a retrospective analysis (ALL-BFM 2000; N = 770 cases) using quantitative polymerase chain reaction to confirm the association of</pubmed_abstract><journal>Blood advances</journal><pubmed_title>The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALL.</pubmed_title><pmcid>PMC7479947</pmcid><funding_grant_id>182269</funding_grant_id><funding_grant_id>156407</funding_grant_id><funding_grant_id>310030</funding_grant_id><pubmed_authors>Wollscheid B</pubmed_authors><pubmed_authors>Zimmermann M</pubmed_authors><pubmed_authors>Temperli M</pubmed_authors><pubmed_authors>Rodriguez Martinez V</pubmed_authors><pubmed_authors>Scheidegger N</pubmed_authors><pubmed_authors>Rinaldi A</pubmed_authors><pubmed_authors>Hauri-Hohl M</pubmed_authors><pubmed_authors>Mirkowska P</pubmed_authors><pubmed_authors>Bruggemann M</pubmed_authors><pubmed_authors>Gaipa G</pubmed_authors><pubmed_authors>Basso G</pubmed_authors><pubmed_authors>Ngo Q</pubmed_authors><pubmed_authors>Vendramini E</pubmed_authors><pubmed_authors>Schrappe M</pubmed_authors><pubmed_authors>Dworzak M</pubmed_authors><pubmed_authors>Attarbaschi A</pubmed_authors><pubmed_authors>Panzer-Grumayer R</pubmed_authors><pubmed_authors>Marovca B</pubmed_authors><pubmed_authors>Eckert C</pubmed_authors><pubmed_authors>Moller C</pubmed_authors><pubmed_authors>Barz MJ</pubmed_authors><pubmed_authors>Yaspo ML</pubmed_authors><pubmed_authors>Schumich A</pubmed_authors><pubmed_authors>Bourquin JP</pubmed_authors><pubmed_authors>Mejstrikova E</pubmed_authors><pubmed_authors>Te Kronnie G</pubmed_authors><pubmed_authors>Buldini B</pubmed_authors><pubmed_authors>Scarparo P</pubmed_authors><pubmed_authors>Niggli F</pubmed_authors><pubmed_authors>Warnatz HJ</pubmed_authors><pubmed_authors>Schutte M</pubmed_authors><pubmed_authors>Skroblyn TL</pubmed_authors><pubmed_authors>Bornhauser B</pubmed_authors><pubmed_authors>Risch T</pubmed_authors><pubmed_authors>Ritgen M</pubmed_authors><pubmed_authors>Stanulla M</pubmed_authors><pubmed_authors>Hofmann A</pubmed_authors><pubmed_authors>Maglia O</pubmed_authors><pubmed_authors>Cario G</pubmed_authors></additional><is_claimable>false</is_claimable><name>The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALL.</name><description>Most relapses of acute lymphoblastic leukemia (ALL) occur in patients with a medium risk (MR) for relapse on the Associazione Italiana di Ematologia e Oncologia Pediatrica and Berlin-Frankfurt-Münster (AIEOP-BFM) ALL protocol, based on persistence of minimal residual disease (MRD). New insights into biological features that are associated with MRD are needed. Here, we identify the glycosylphosphatidylinositol-anchored cell surface protein vanin-2 (VNN2; GPI-80) by charting the cell surface proteome of MRD very high-risk (HR) B-cell precursor (BCP) ALL using a chemoproteomics strategy. The correlation between VNN2 transcript and surface protein expression enabled a retrospective analysis (ALL-BFM 2000; N = 770 cases) using quantitative polymerase chain reaction to confirm the association of</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Sep</publication><modification>2026-04-15T09:03:33.118Z</modification><creation>2020-09-12T07:08:46Z</creation></dates><accession>S-EPMC7479947</accession><cross_references><pubmed>32853382</pubmed><doi>10.1182/bloodadvances.2019000938</doi></cross_references></HashMap>